Dallas, TX -- (SBWIRE) -- 11/24/2010 -- SandlerResearch announce Endometriosis - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, “Endometriosis - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global endometriosis market. The report identifies the key trends shaping and driving the global endometriosis market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global endometriosis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimates that the global endometriosis market was valued at $785m in 2009 and will grow at a Compound Annual Growth Rate (CAGR) of 4.3% to reach $1.1 billion by 2017. This modest growth forecast is primarily attributed to a weak pipeline landscape. The existing market is weak due to a lack of diagnostic techniques, disease awareness and the poor safety and efficacy profiles of the existing therapies. There is a high unmet need which is largely driven by the availability of drugs that are moderately successful in terms of safety and efficacy. The endometriosis market is primarily formed of generic and off-label drugs and has very few approved drugs which fall in the major therapeutic categories such as NSAIDs, oral contraceptives, GnRH agonists and progestins
Scope
The report provides information on the key drivers and challenges of the endometriosis market. Its scope includes:
Annualized global endometriosis market revenues data from 2001 to 2009, forecast for eight years to 2017.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as GnRH antagonists, GnRH synergists, aromatase inhibitors, antiprogestins and steroid sulfatase inhibitors.
Analysis of the current and future competition in the global endometriosis market. Key market players covered are Bayer Healtcare Pharmaceuticals, Pfizer Inc, Neurocrine Biosciences Inc., Æterna Zentaris Inc. and Repros Therapeutics Inc.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the endometriosis therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global endometriosis market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global endometriosis market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global endometriosis market landscape? – Identify, understand and capitalize.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Endometriosis: Introduction 4
2.1 GlobalData Pipeline Report Guidance 4
3 Endometriosis: Market Characterization 5
3.1 Endometriosis Therapeutics Market Size 5
3.2 Endometriosis Therapeutics Market Forecast and CAGR 6
3.3 Drivers and Barriers for the Endometriosis Therapeutics Market 7
3.3.1 Drivers for Endometriosis Therapeutics Market 7
3.3.2 Barriers for the Endometriosis Therapeutics Market 8
3.4 Opportunity and Unmet Need 8
3.5 Key Takeaway 9
4 The Endometriosis Therapeutics Market: Competitive Assessment 10
4.1 Overview 10
4.2 Strategic Competitor Assessment 10
4.3 Major Therapies in the Endometriosis Therapeutics Market 11
4.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Endometriosis 11
4.3.2 Gonadotropin-Releasing Hormone (GnRH) agonists 11
4.3.3 Birth Control Hormones for Endometriosis 13
4.3.4 Progestins for Endometriosis 13
4.3.5 Danazol 14
4.4 Key Takeaway 15
5 Endometriosis Therapeutics Market: Pipeline Assessment 16
5.1 Overview 16
5.2 Strategic Pipeline Assessment 16
5.2.1 Technology Trends Analytic Framework 16
5.3 Endometriosis Therapeutics – Promising Drugs Under Clinical Development 17
5.4 Molecule Profile for Promising Drugs under Clinical Development 18
5.4.1 Visanne 18
5.4.2 Proellex 18
5.4.3 Elagolix (NBI-56418) 19
5.4.4 MPI-676 20
5.5 Endometriosis Therapeutics Market – Clinical Pipeline by Mechanism of Action 21
5.6 Endometriosis Disease Pipeline – Pipeline by Phase of Clinical Development 21
5.6.1 Endometriosis Therapeutics – Phase III and Regulatory Filed Clinical Pipeline 22
5.6.2 Endometriosis Therapeutics – Phase II Clinical Pipeline 22
5.6.3 Endometriosis Therapeutics – Phase I Clinical Pipeline 22
5.6.4 Endometriosis Therapeutics – Preclinical Pipeline 22
5.7 Key Takeaway 23
6 Global Endometriosis Therapeutics Market: Implications for Future Market Competition 24
7 Endometriosis: Future Players in Endometriosis therapeutics market 25
7.1 Introduction 25
7.2 Bayer AG 25
7.2.1 Company Overview 25
7.2.2 Business Description 26
7.3 Pfizer Inc. 27
7.3.1 Company Overview 27
7.3.2 Business Description 28
7.4 Æterna Zentaris Inc. 29
7.4.1 Company Overview 29
7.4.2 Business Description 29
7.5 Neurocrine Biosciences, Inc. 30
7.5.1 Company Overview 30
7.5.2 Business Description 30
7.6 Repros Therapeutics, Inc 31
7.6.1 Company Overview 31
7.6.2 Business Description 31
7.7 Meditrina Pharmaceuticals, Inc. 32
7.7.1 Company Overview 32
8 Global Endometriosis Therapeutics Market: Appendix 33
8.1 Definitions 33
8.2 Scope of Pipeline Research 33
8.3 Acronyms 33
8.4 Research Methodology 34
8.4.1 Coverage 34
8.4.2 Secondary Research 34
8.4.3 Forecasting 34
8.4.4 Primary Research 37
8.4.5 Expert Panels 37
8.5 Contact Us 37
8.6 Disclaimer 38
8.7 Sources 38
ABBREVIATIONS
Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports :
Global market review of automotive roof systems – forecasts to 2017
http://www.sandlerresearch.org/Reports/17319-global-market-review-of-automotive-roof-systems-forecasts-to-20.html
Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
http://www.sandlerresearch.org/Reports/7196-pipeline-insight-endometriosis-new-therapies-near-market-while.html
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html
Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25475-global-hospital-information-systems-his-opportunity-assessment.html
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
http://www.sandlerresearch.org/Reports/34583-forecast-insight-antidiabetics--diabetes-market-growth-driven.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/
Original Source : Endometriosis Market
http://www.sandlerresearch.org/reports/32789-endometriosis-pipeline-assessment-and-market-forecasts-to-2017.html
Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html
Browse complete Report at : Endometriosis - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/32789-endometriosis-pipeline-assessment-and-market-forecasts-to-2017.html